Plasmodium infection inhibits triple negative 4T1 breast cancer potentially through induction of CD8+ T cell-mediated antitumor responses in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasmodium infection inhibits triple negative 4T1 breast cancer potentially through induction of CD8+ T cell-mediated antitumor responses in mice

Published:2021-06 Issue: Volume:138 Page:111406
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Pan Jianhua,Ma Meng,Qin Li,Kang Zhongkui,Adah Dickson,Tao Zhu,Li Xiaofen,Dai Linglin,Zhao Siting,Chen Xiaoping,Zhou Qin

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference26 articles.

1. Globocan. The Global Cancer Observatory (GCO) (2018) Cancer Today, 2018. 〈http://gco.iarc.fr/today/online-analysis〉.

2. Triple negative tumours: a critical review;Reis-Filho;Histopathology,2008

3. Triple-negative breast cancer and the potential for targeted therapy;Jhan;Pharmacogenomics,2017

4. Immunotherapy: the end of the “dark age” for metastatictriple-negative breast cancer?;Palleschi;Breast J.,2019

5. Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer;Criscitiello;Cancer Treat. Rev.,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Nociceptive and Inflammatory Responses Induced by the Ehrlich Solid Tumor Are Changed in Mice Healed of Plasmodium berghei Strain ANKA Infection after Chloroquine Treatment;Journal of Parasitology Research;2024-05-14

2. From immune equilibrium to tumor ecodynamics;Frontiers in Oncology;2024-05-10

3. A novel enemy of cancer: recent investigations into protozoan anti-tumor properties;Frontiers in Cellular and Infection Microbiology;2024-01-11

4. Plasmodium immunotherapy combined with gemcitabine has a synergistic inhibitory effect on tumor growth and metastasis in murine Lewis lung cancer models;Frontiers in Oncology;2023-10-17

5. Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes;Frontiers in Oncology;2023-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3